153 related articles for article (PubMed ID: 9657948)
1. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
2. Resistance to antiviral inhibitors caused by the mutation S889A in the highly-conserved 885-GDTDS motif of the herpes simplex virus type 1 DNA polymerase.
Dorsky DI; Plourde C
Virology; 1993 Aug; 195(2):831-5. PubMed ID: 8337848
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
4. The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region.
Loregian A; Piaia E; Cancellotti E; Papini E; Marsden HS; Palù G
Virology; 2000 Jul; 273(1):139-48. PubMed ID: 10891416
[TBL] [Abstract][Full Text] [Related]
5. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
6. Mutations within conserved motifs in the 3'-5' exonuclease domain of herpes simplex virus DNA polymerase.
Hall JD; Orth KL; Sander KL; Swihart BM; Senese RA
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2999-3008. PubMed ID: 8847505
[TBL] [Abstract][Full Text] [Related]
7. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Hwang YT; Zuccola HJ; Lu Q; Hwang CB
J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
Bestman-Smith J; Boivin G
J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
[TBL] [Abstract][Full Text] [Related]
9. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice.
Pelosi E; Rozenberg F; Coen DM; Tyler KL
Virology; 1998 Dec; 252(2):364-72. PubMed ID: 9878615
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
11. An importin alpha/beta-recognized bipartite nuclear localization signal mediates targeting of the human herpes simplex virus type 1 DNA polymerase catalytic subunit pUL30 to the nucleus.
Alvisi G; Musiani D; Jans DA; Ripalti A
Biochemistry; 2007 Aug; 46(32):9155-63. PubMed ID: 17640102
[TBL] [Abstract][Full Text] [Related]
12. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
[TBL] [Abstract][Full Text] [Related]
13. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
Saijo M; Suzutani T; Morikawa S; Kurane I
Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
15. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
[TBL] [Abstract][Full Text] [Related]
16. Emergence of resistance to carbocyclic oxetanocin G in herpes simplex virus type 1 and genetic analysis of resistant mutants.
Hu N; Shiota H
Acta Pharmacol Sin; 2004 Jul; 25(7):921-6. PubMed ID: 15210066
[TBL] [Abstract][Full Text] [Related]
17. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.
Biswas S; Jennens L; Field HJ
Arch Virol; 2007; 152(8):1489-500. PubMed ID: 17404685
[TBL] [Abstract][Full Text] [Related]
18. Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.
Tian W; Hwang YT; Lu Q; Hwang CB
J Virol; 2009 Jul; 83(14):7194-201. PubMed ID: 19420083
[TBL] [Abstract][Full Text] [Related]
19. Exonuclease-deficient polymerase mutant of herpes simplex virus type 1 induces altered spectra of mutations.
Hwang YT; Hwang CB
J Virol; 2003 Mar; 77(5):2946-55. PubMed ID: 12584319
[TBL] [Abstract][Full Text] [Related]
20. Phage phi 29 DNA polymerase residues involved in the proper stabilisation of the primer-terminus at the 3'-5' exonuclease active site.
de Vega M; Lázaro JM; Salas M
J Mol Biol; 2000 Nov; 304(1):1-9. PubMed ID: 11071805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
